BAMS
ALXN

Bellevue Asset Management (Switzerland)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q4 		$9.42M Hold
49,400
– – 1.44% 19
2015
Q3 		$7.73M Sell
49,400
-2,346
-5% -$367K 1.26% 23
2015
Q2 		$9.35M Sell
51,746
-21,000
-29% -$3.8M 1.3% 24
2015
Q1 		$12.6M Buy
+72,746
New +$12.6M 1.76% 12